Cosmetics Europe re-elected Isabelle Martin as President and Birgit Huber as VP during the trade association’s General Assembly in Brussels 20 June. The EU Green Deal and its numerous entanglements continue to loom large in the group’s strategic programming.
The Estee Lauder Companies, Inc.’s Isabelle Martin identified the implementation of the Green Deal legislation and supporting the industry’s sustainability journey as “key” priorities upon her re-election as president of Cosmetics Europe at the trade association’s General Assembly on 20 June.
“At the same time, we hope that EU policy makers will focus on keeping our industry competitive under the new...
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
